Lessons From Lockdown: Evolving Models of Care for Liver Diseases

In this call between colleagues, expert faculty discuss what they learned during the COVID-19 pandemic about strategies to care for patients with HCV infection, including patients who inject drugs.

Gregory Dore, MBBS, PhD, FRACP, MPH Stacey Trooskin, MD, PhD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: October 1, 2021 Expired: September 30, 2022

Review key slides from liver experts around the globe about lessons learned from the COVID-19 pandemic worth carrying forward.

Gregory Dore, MBBS, PhD, FRACP, MPH Stacey Trooskin, MD, PhD, MPH Released: September 23, 2021

The COVID-19 pandemic has provided the impetus for nimble and creative strategies that meet patients where they are. In the United States, telemedicine visits are one such strategy—and we should carry them forward in the delivery of care.

Stacey Trooskin, MD, PhD, MPH Released: September 29, 2021